LAMTOR5 and breast carcinoma: One possible reason for the development of chemo-/radiotherapy resistance in breast cancer is that the ROS induced by chemo-/radiotherapy can activate positive HBXIP/Nrf2 feedback (Fig. 5 and Supplementary Fig. 1K) and reinforce their respective tumor-promoting actions32,33.